Our commitment
to addressing the
covid-19 pandemic

At Abbott, the health and well-being of our customers and communities is our top priority. 

For more than 130 years, we've put science and innovation to work - to create more possibilities for more people through the power of health. We adapt and respond quickly to changes in the world around us to deliver better solutions to help people live their best lives.

That commitment remains as we work to ensure continued supply, service and support to our valued customers and healthcare professionals during these times of global uncertainty. 

abbott covid-19 product availability

Announcing sars-cov-2
immunoassays

Serology testing is an important next step in combating the
covid-19 pandemic. our US FDA emergency use authorized automated
lab-based test detects the human antibody response to the novel
coronavirus. antibody testing provides additional options to test
patients and conduct covid-19 research.

molecular test offerings for
lab testing covid-19

to help with the need for automated, high volume covid-19 testing,
Abbott has launched 2 molecular tests under the u.s. food and
drug administration emergency use authorization (eua) to run
on the Alinity m and m2000 system.

Introducing ID NOW™ COVID-19
rapid point-of-care test

The ID NOW™ COVID-19 assay is now available under U.S. FDA
Emergency Use Authorization (EUA). High-quality molecular
positive results in as little as 5 minutes, targeting covid-19
rdrp gene (emergency use only). click for more information.

patient monitoring

Monitoring in the Lab

With increased patient volume at healthcare facilities and the associated scarcity of
resources, evaluating disease severity can help optimize resource utilization by
ensuring that the appropriate level of treatment is provided. 

HEMATOLOGY

The complete blood count (CBC), one of the most commonly performed tests
in the world, can be a fast and cost-effective way to support patient assessments.

Learn More

procalcitonin (pct)

Recent studies suggest the value of PCT testing among COVID-19 patients, as some
patients may experience bacterial infections. This testing will help indicate who may
benefit from antibiotics as part of their treatment.

Read More about PCT Learn More

Blood gas monitoring at the
point-of-care

healthcare facilities are being challenged in increased patient
volume and the need for continued monitoring of blood gases
in respiratory care patients. Testing with portable, handheld
i‑STAT analyzers facilitates real-time decisions to optimize care.

abbott covid-19 information

helping to prevent
the spread

Abbott is on the frontlines of the covid-19
response with critical tests that will help
protect our communities.

Additional covid-19 resources

 

As the situation concerning COVID-19 changes day to day, the following links may help you stay up-to-date on the latest developments. 


U.S. Food & Drug Administration (FDA)


Get the facts 

Center for Disease Control (CDC)


Get the facts 

World Health Organization (WHO)


Get the Facts 

American Association for Clinical chemistry (AACC)

Get the facts 

 join the conversation

LinkedIn_Icon_Blue_TM

Follow the Abbott Diagnostics LinkedIn Channel for the latest news from our company and within the in vitro diagnostics industry.

Follow us


FOR THE LATEST ON

CORONAVIRUS,

GET ABBOTT EDGE DIRECTLY

TO YOUR INBOX


Sign up

The Abbott SARS-C0V-2 IgG assay has not been FDA cleared or approved. It has been authorized by the FDA under EUA for use by authorized laboratories. This test has been authorized only for the detection of IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

The Abbott RealTime SARS-CoV-2 assay and the Alinity m SARS-CoV-2 assay have not been FDA cleared or approved. These tests have been authorized by the FDA under an Emergency Use Authorization for use by authorized laboratories. These tests have been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens, and are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

The ID NOW COVID-19 EUA has not been FDA cleared or approved. It has been authorized by the FDA under an emergency use authorization for use by authorized laboratories and patient care settings. The test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens, and is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 546(b)(1) of the Act, 21 U.S.C  § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

The Abbott Point of Care i-STAT system does not offer any test cartridges for the diagnosis of COVID-19.

ChooseTransformationBanner_1457x55.jpg

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.

Do you wish to continue and exit this website?

Yes No

You are about to enter an Abbott country or region specific website.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

Do you wish to continue and enter this website?

Yes No

DO YOU WISH TO CONTINUE AND EXIT THE DIAGNOSTICS WEBSITE?

Content is not under the control of diagnostics.abbott.

Yes No